Biomason announced a $65M funding round led by 2150 with participation from Celesta Capital, Hartree Partners, and others, including
current shareholders Novo Holdings and Martin Marietta Materials (MLM).

Biomason's mission is to lead the global transition to planet-friendly construction. The firm is eliminating the need to emit carbon in cement production-curing the disease instead of treating the symptoms. Biomason biocement will reduce 25% of carbon emission from the global concrete industry by 2030.